Binge Eating Disorder: Meta-analyses and Systematic Reviews of Treatment

Binge eating disorder (BED), a formal eating disorder diagnosis in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), is characterized by recurrent binge eating, marked distress about binge eating, and the absence of extreme weight compensatory behaviors. BED is more prevalent than other eating disorders, with broader distribution across age, sex and ethnic/racial groups, and is associated strongly with obesity and heightened risk for psychiatric/medical comorbidities. This line of research periodically updates and summarizes the evidence on the effectiveness of different pharmacotherapy and psychological treatments for individuals with BED.

Contact person Deborah Lynn Reas. 

Publications:

Reas DL, Grilo CM (2020). Psychotherapy and Medications for Eating Disorders: Better Together? Clin Ther, 43 (1), 17-39. DOI 10.1016/j.clinthera.2020.10.006, PubMed 33342555

Grilo CM, Reas DL, Mitchell JE (2016). Combining Pharmacological and Psychological Treatments for Binge Eating Disorder: Current Status, Limitations, and Future Directions. Curr Psychiatry Rep, 18 (6), 55. DOI 10.1007/s11920-016-0696-z, 

Reas DL, Grilo CM (2015). Pharmacological treatment of binge eating disorder: update review and synthesis. Expert Opin Pharmacother, 16 (10), 1463-78
DOI 10.1517/14656566.2015.1053465, PubMed 26044518

Reas, DL, Grilo CM (2008). Review and meta-analysis of pharmacotherapy for binge-eating disorder. Obesity (Silver Spring), 16 (9), 2024-38. DOI 10.1038/oby.2008.333